Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT05879406 Recruiting - Non-Cystic Acne Clinical Trials

A Study to Evaluate the Efficacy and Safety of Clear Skin Formula on Mitigating Mild to Moderate Non-cystic Acne

Start date: May 22, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to compare Clear Skin Fomula Supplement to Placebo in healthy men and women ages 18-40 to mitigate mild to moderate non-cystic acne over the course of 12 weeks. Participants will be asked to take a daily supplement, have photos of their face taken and answer questionnaires related to their acne.

NCT ID: NCT05861063 Recruiting - Acne Atrophica Clinical Trials

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

Start date: February 11, 2023
Phase: Phase 4
Study type: Interventional

The Efficacy and Safety of Dezocine Pretreatment for Pain Relief in Acne Scar Treatment of Fractional CO2 Laser

NCT ID: NCT05830968 Recruiting - Clinical trials for Inflammatory Acne Vulgaris

Safety and Efficacy of Radio Frequency for the Treatment of Mild to Severe Inflammatory Acne

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The aim of this trial is to evaluate the safety and efficacy of the InMode RF Pro System with the Morpheus8 face tip (24 pins) applicator for the treatment of mild, moderate and severe, facial acne vulgaris

NCT ID: NCT05755256 Recruiting - Acne Vulgaris Clinical Trials

The Impact of Probiotics on Skin Hydration in Youth With Mild Acne

YSH
Start date: September 4, 2023
Phase: Phase 2
Study type: Interventional

The goal of this clinical trials is to test the impact of probiotics on skin hydration in adolescents and young adults with mild acne. The hypothesis of this study is that the probiotic formulation is superior to placebo in improving the skin hydration in adolescents and young adults with minimal acne after 12 weeks of consumption.

NCT ID: NCT05597267 Recruiting - Clinical trials for Acne Scars - Mixed Atrophic and Hypertrophic

The MIRIA Acne Scar Study

MIRIA
Start date: November 4, 2022
Phase: N/A
Study type: Interventional

This study is being conducted to evaluate the performance and efficacy of the AVAVA MIRIA Laser Skin System treatment on acne scars. Participants will be treated with the MIRIA laser at least 4 times with each treatment spaced 4-6 weeks apart. The improvement of acne scars will be evaluated at 1 month and 3 months with a possibility of 6 months evaluation after the fourth treatment.

NCT ID: NCT05430464 Recruiting - Acne Vulgaris Clinical Trials

A Study of a Laser for the Treatment of Acne Vulgaris

Start date: July 27, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the onset, duration, efficacy and safety of the laser for the treatment of acne vulgaris.

NCT ID: NCT05301569 Recruiting - Clinical trials for Evaluation of Serum Level of Insulin Like Growth Factor 1

Relation Between Serum IGF-1 & BMI In Acne Vulgaris

Start date: April 1, 2023
Phase:
Study type: Observational

cross-sectional study in which participants will be recruited at dermatology & Andrology out-patient clinics in Assuit university hospital, Egypt after patients examination by dermatologists & obtaining an informed consent

NCT ID: NCT05269641 Recruiting - Acne Vulgaris Clinical Trials

Almond Supplementation on Mild to Moderate Acne

Start date: February 28, 2022
Phase: N/A
Study type: Interventional

This study will assess the effect of almond supplementation on acne and on gut health.

NCT ID: NCT05245045 Recruiting - Acne Clinical Trials

Efficacy and Safety of STBF Photodynamic Therapy for Moderate and Severe Acne Vulgaris

Start date: February 10, 2022
Phase: N/A
Study type: Interventional

This study is being done to evaluate the efficacy and safety of Shengtaibufen photodynamic therapy (STBF-PDT) for treatment of moderate or severe acne vulgaris.

NCT ID: NCT05186246 Recruiting - Acne Vulgaris Clinical Trials

Effectivity and Safety of Combination of Spent Grain Wax, Argan Oil, Shea Butter and Saccharide Isomerate

Start date: December 20, 2021
Phase: Phase 1
Study type: Interventional

The clinical study will compare the efficacy and safety of Combination of Spent Grain Wax, Argan Oil, Shea Butter and Saccharide Isomerate cream post fractional CO2 laser. Combination of Spent Grain Wax, Argan Oil, and Shea Butter was formulated to reduce skin irritation and allergy symptoms such as dryness, itch and rash. The combination cream applied on one side of the face while placebo will be applied on the other side of the face in 18-60 years old female post fractional CO2 laser.